円形脱毛症市場、2034年までに約27%のCAGRで成長とDelveInsightが予測
2025年 04月 25日
The alopecia areata market is witnessing rapid transformation with key players such as Arcutis Biotherapeutics, Bioniz Therapeutics, Reistone Biopharma, Pfizer, Suzhou Zelgen Biopharmaceuticals, Eli Lilly, Incyte, Aclaris Therapeutics, Legacy Healthcare, Concert Pharmaceuticals, LEO Pharma, and Bristol-Myers Squibb driving innovation and growth.
Alopecia Areata Market Overview (Albany, USA) – DelveInsight's report, "Alopecia Areata Market Insights, Epidemiology, and Market Forecast - 2034" provides a comprehensive analysis of the alopecia areata landscape in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan. The report provides valuable insights into current treatment approaches, disease epidemiology, market trends, and forecasts for 2020-2034.
The report explores market dynamics including current treatments, emerging treatment options, market drivers and barriers, and unmet needs, designed to identify opportunities with high commercial potential and assess the overall growth trajectory of the Alopecia Areata market.
👉 Request a Free Sample Report @Alopecia Areata Market Forecast
Key highlights of the report:
The alopecia areata market is projected to grow at a CAGR of approximately 27% until 2034 according to DelveInsight.
The combined market size (7MM) of the seven major markets is estimated to be: $180 Million in 2023 ;
Some of the major pharmaceutical companies operating in this field include: Arctis Biotherapeutics, Pfizer, Eli Lilly, Riceton Biopharma, Bionis Therapeutics, Aclaris Therapeutics , and several others.
Some notable emerging therapies expected to impact the market include: abatacept, tralokinumab, secukinumab, BNZ 1, litecitinib, ifidacitinib, delgocitinib, etrasimod, baricitinib, brepocitinib , and others.
Increasing R&D investments and strong pipelines from leading companies are set to strengthen the future treatment environment.
Alopecia Areata: Disease Overview
Alopecia areata is a chronic autoimmune disease in which the immune system attacks hair follicles, leading to patchy hair loss on the scalp and body. Although the condition is not life-threatening, its unpredictable and relapsing nature has a significant impact on psychological and emotional health.
There is no definitive cure, but a variety of treatments, including corticosteroids, immunotherapy and JAK inhibitors, are used to manage symptoms and promote hair growth. Cosmetic approaches, such as wigs and scalp camouflage, are also commonly employed.
📌 Learn more about treatment algorithms and patient progress – Request a sample @Alopecia Areata Treatment Market
Alopecia Areata Market Analysis
DelveInsight's market landscape segment provides a detailed understanding of past, current, and projected market trends. It evaluates each approved and pipeline therapy based on factors such as:
Treatment costs
Mechanism of action
Patient Pool
Market competition
Brand Value
Compliance rate
Launch Timeline
Visual data representation in the form of graphs and tables provides quick insights into the evolving market situation.
Epidemiology of alopecia areata
This section provides details on:
Past and current patient numbers
Diagnosed prevalence and predicted trends across the 7MM
Key factors driving epidemiological trends
KOL Expert Perspectives on Diagnosis and Treatment
🔍 Learn more about epidemiology and patient segmentation @Alopecia Areata Market Trends and Trends
Drug uptake and pipeline development
The report highlights that:
Newly launched therapies and expected therapy uptake patterns from 2020 to 2034
Market penetration rates, sales trends and competitive benchmarks for each treatment
Key factors influencing adoption (e.g., regulatory approval, efficacy, unmet need)
PIPELINE INSIGHTS Phase II and III treatments are evaluated for clinical progress and commercial potential. Lead developers include Arcutis Biotherapeutics, Pfizer, Bioniz Therapeutics, Eli Lilly, Reistone Biopharma and Concert Pharmaceuticals , among others.
📥 If you want to know more about our pipeline, request a sample @ https://www.delveinsight.com/report-store/alopecia-areata-market
Report Scope:
Geographical coverage : US, EU5, Japan
Study period : 2020–2034
Key Players : Arcutis Biotherapeutics, Eli Lilly, Pfizer, Aclaris Therapeutics, LEO Pharma, Reistone Biopharma, etc.
Targeted treatments : Abatacept, tralokinumab, litecitinib, ifdancitinib, delgocitinib, baricitinib, etc.
🧪 For clinical trial and regulatory updates, see: Alopecia Areata Clinical Trials and FDA Approval
Report highlights:
Number of cases and prevalence
Overall 7MM market trends and size
Competitive environment and major companies
Market Drivers, Barriers and Opportunities
Drug Development and Pipeline Analysis
Treatment algorithms and medical procedures
Unmet needs and the impact of new treatments
Table of contents (overview):
Key Insights
executive summary
Competitive analysis
Market Snapshot
Background of the disease
The patient journey
Epidemiology insights
Treatment Practice
Unmet needs
Primary Endpoint
Over-the-counter treatments
Pipeline Therapies
7MM Market Analysis
Attribute Evaluation
Forecast outlook
Access and Refunds
KOL Perspective
Market Drivers
Market Barriers
appendix
DelveInsight Features
Disclaimer
About DelveInsight DelveInsight is a leading life sciences market research and business consulting company, providing in-depth reports and customized solutions to stakeholders across the healthcare ecosystem.
